Yang et al. found upregulated circ-LDLRAD3 in the plasma of patients with pancreatic cancer that could be used as a biomarker in diagnosing pancreatic cancer [106]. This evidence concerns the gene LDLRAD3 and familial pancreatic carcinoma.